|
DE69633565T3
(de)
|
1995-06-15 |
2013-01-17 |
Crucell Holland B.V. |
Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
|
|
US20030082767A1
(en)
*
|
1997-09-18 |
2003-05-01 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6391311B1
(en)
*
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
|
US7723488B2
(en)
*
|
1998-03-27 |
2010-05-25 |
Genentech, Inc. |
Monoclonal antibodies to secreted and transmembrane polypeptides
|
|
US7371836B2
(en)
*
|
1998-03-27 |
2008-05-13 |
Genentech, Inc. |
PRO526 nucleic acids
|
|
CA2331154A1
(en)
|
1998-06-16 |
1999-12-23 |
Human Genome Sciences, Inc. |
Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
|
|
US20070020724A1
(en)
|
1998-06-16 |
2007-01-25 |
Ruben Steven M |
94 human secreted proteins
|
|
US7071304B2
(en)
*
|
1998-09-01 |
2006-07-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7399834B2
(en)
*
|
1998-10-07 |
2008-07-15 |
Genentech, Inc. |
Anti-PRO1558 antibodies
|
|
US7026449B2
(en)
*
|
1999-01-05 |
2006-04-11 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
PT1623990E
(pt)
*
|
1999-03-08 |
2008-03-18 |
Genentech Inc |
Composições e métodos para o tratamento de tumores
|
|
US6855544B1
(en)
*
|
1999-04-15 |
2005-02-15 |
Crucell Holland B.V. |
Recombinant protein production in a human cell
|
|
US7604960B2
(en)
*
|
1999-04-15 |
2009-10-20 |
Crucell Holland B.V. |
Transient protein expression methods
|
|
US20050164386A1
(en)
*
|
1999-04-15 |
2005-07-28 |
Uytdehaag Alphonsus G. |
Overexpression of enzymes involved in post-translational protein modifications in human cells
|
|
US8236561B2
(en)
*
|
1999-04-15 |
2012-08-07 |
Crucell Holland B.V. |
Efficient production of IgA in recombinant mammalian cells
|
|
US7297680B2
(en)
*
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
US20060099685A1
(en)
*
|
1999-04-15 |
2006-05-11 |
Yallop Christopher A |
Recombinant expression of factor VIII in human cells
|
|
AU3632600A
(en)
*
|
1999-05-14 |
2000-12-05 |
Genentech Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20050079577A1
(en)
*
|
1999-05-14 |
2005-04-14 |
Ashkenazi Avi J. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6500940B1
(en)
*
|
1999-06-09 |
2002-12-31 |
The Salk Institute For Biological Studies |
Lifeguard (LFG) polynucleotides and polypeptides and methods of use thereof
|
|
US6114123A
(en)
*
|
1999-06-14 |
2000-09-05 |
Incyte Pharmaceuticals, Inc. |
Lipocalin family protein
|
|
US6369210B1
(en)
*
|
1999-06-30 |
2002-04-09 |
Millennium Pharmaceuticals, Inc. |
22012, human carboxypeptidase
|
|
AU5979300A
(en)
*
|
1999-07-02 |
2001-01-22 |
Bayer Aktiengesellschaft |
Angiopoietin-6 and uses thereof
|
|
EP1233777A4
(en)
*
|
1999-11-24 |
2003-07-16 |
Human Genome Sciences Inc |
MAJOR INTRINSIC PROTEIN (MIP) -LIKE POLYNUCLEOTIDES, POLYPEPTIDES AND ANTIBODIES
|
|
US7527961B2
(en)
*
|
1999-11-26 |
2009-05-05 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7192759B1
(en)
*
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
US7521220B2
(en)
*
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
HUP0203863A3
(en)
*
|
2000-01-12 |
2008-03-28 |
Univ Yale |
Nogo receptor-mediated blockade of axonal growth
|
|
US7119165B2
(en)
|
2000-01-12 |
2006-10-10 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
|
WO2001060854A1
(en)
*
|
2000-02-14 |
2001-08-23 |
The Regents Of The University Of California |
Novel members of the h+/oligopeptide transporter gene family
|
|
WO2001062929A2
(en)
*
|
2000-02-25 |
2001-08-30 |
Curagen Corporation |
Sodium/solute symporter-like protein and nucleic acids encoding same
|
|
WO2001064878A2
(en)
*
|
2000-02-29 |
2001-09-07 |
Lexicon Genetics Incorporated |
Human transporter proteins and polynucleotides encoding the same
|
|
US7070947B2
(en)
|
2000-02-29 |
2006-07-04 |
Millennium Pharmaceuticals, Inc. |
Human protein kinase, phosphatase, and protease family members and uses thereof
|
|
WO2001070244A1
(en)
*
|
2000-03-16 |
2001-09-27 |
Northwest Biotherapeutics, Inc. |
Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
|
|
WO2001077151A2
(en)
*
|
2000-04-07 |
2001-10-18 |
Millennium Pharmaceuticals, Inc. |
Fdrg proteins and nucleic acid molecules and uses therefor
|
|
AU2001246905A1
(en)
*
|
2000-04-12 |
2001-10-23 |
Takeda Chemical Industries Ltd. |
Novel g protein-coupled receptor protein and dna thereof
|
|
US20020077462A1
(en)
*
|
2000-04-14 |
2002-06-20 |
Curtis Rory A. J. |
33556, a novel human transporter and uses thereof
|
|
AU2001257378A1
(en)
*
|
2000-04-29 |
2001-11-12 |
Millennium Pharmaceuticals, Inc. |
23949 and 32391, human ion channels and uses thereof
|
|
US20050170413A1
(en)
*
|
2000-07-03 |
2005-08-04 |
Applera Corporation |
Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
|
|
GB2371546A
(en)
*
|
2000-09-12 |
2002-07-31 |
Smithkline Beecham Corp |
G protein coupled receptor AXOR 109
|
|
CA2420192A1
(en)
*
|
2000-09-20 |
2002-03-28 |
Human Genome Sciences, Inc. |
21 human secreted proteins
|
|
ES2341608T3
(es)
|
2000-10-06 |
2010-06-23 |
Yale University |
Homologos del receptor de nogo.
|
|
AU2001296033A1
(en)
|
2000-11-17 |
2002-05-27 |
Banyu Pharmaceutical Co. Ltd. |
Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein, bg37
|
|
UA79927C2
(en)
*
|
2000-12-05 |
2007-08-10 |
Serono Genetics Inst Sa |
Polynucleotide, coding a polypeptide of potential-depending portal ionic human channel (canion), polypeptyde, antibody, method for identification of candidate modulator of canion-polypeptyde, method for treatment of bipolar disorder or schizophrenia and use of an antibody for production of drugs for treatment of schizophrenia or bipolar disorder
|
|
WO2002084286A1
(en)
*
|
2001-04-12 |
2002-10-24 |
Takeda Chemical Industries, Ltd. |
Screening method
|
|
JP2004535787A
(ja)
*
|
2001-04-13 |
2004-12-02 |
インサイト・ゲノミックス・インコーポレイテッド |
酵素
|
|
DE60228559D1
(de)
*
|
2001-04-25 |
2008-10-09 |
Astellas Pharma Inc |
Guanosintriphosphat-bindungsprotein-gekoppelter rezeptor place 6002312 und sein gen sowie dessen produktion und verwendung
|
|
WO2002088363A2
(en)
*
|
2001-05-02 |
2002-11-07 |
Bayer Healthcare Ag |
Regulation of novel human prolyl 4-hydroxylases
|
|
CA2447662A1
(en)
*
|
2001-05-25 |
2002-12-05 |
Incyte Genomics, Inc. |
Transporters and ion channels
|
|
CA2399569A1
(en)
*
|
2001-09-25 |
2003-03-25 |
Yusuke Nakamura |
Diagnostic markers and drug targets for treatment of cancer
|
|
US20050123925A1
(en)
|
2002-11-15 |
2005-06-09 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
ATE384785T1
(de)
*
|
2001-12-07 |
2008-02-15 |
Crucell Holland Bv |
Herstellung von viren, virusisolaten, und impfstoffen
|
|
JP2005538683A
(ja)
*
|
2001-12-14 |
2005-12-22 |
ターガセプト，インコーポレイテッド |
中枢神経系疾患の治療のための方法及び組成物
|
|
ATE469913T1
(de)
*
|
2002-08-10 |
2010-06-15 |
Univ Yale |
Antagonisten des nogo-rezeptors
|
|
US20040214237A1
(en)
*
|
2002-10-03 |
2004-10-28 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF138 and uses thereof
|
|
CN1832752A
(zh)
*
|
2003-04-16 |
2006-09-13 |
耶鲁大学 |
治疗淀粉样蛋白斑相关性病症的nogo－受体拮抗剂
|
|
NZ542585A
(en)
*
|
2003-05-09 |
2007-11-30 |
Crucell Holland Bv |
Cultures of PER.C6-immortalized cells and processes for culturing the same to increase product yields therefrom
|
|
DK1626992T3
(da)
*
|
2003-05-23 |
2010-09-20 |
Crucell Holland Bv |
Produktion af rekombinant IgM i PER.C6-celler
|
|
JP2007501612A
(ja)
*
|
2003-08-07 |
2007-02-01 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｎｏｇｏ受容体アンタゴニスト
|
|
JP2007508020A
(ja)
*
|
2003-09-30 |
2007-04-05 |
カイロン コーポレイション |
ヒトｄｋｋｌ１の新規スプライス改変体
|
|
DE10350409A1
(de)
*
|
2003-10-28 |
2005-05-25 |
Bayer Healthcare Ag |
Behandlung genetisch bedingter Krankheiten
|
|
WO2005079345A2
(en)
*
|
2004-02-12 |
2005-09-01 |
Rush University Medical Center |
Fluid composition used to simulate human synovial fluid
|
|
US7189691B2
(en)
*
|
2004-04-01 |
2007-03-13 |
The Administrators Of The Tulane Educational Fund |
Methods and compositions for treating leukemia
|
|
US20050281740A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue
|
|
US7608579B2
(en)
*
|
2004-06-16 |
2009-10-27 |
Pneumrx, Inc. |
Lung volume reduction using glue compositions
|
|
US7553810B2
(en)
*
|
2004-06-16 |
2009-06-30 |
Pneumrx, Inc. |
Lung volume reduction using glue composition
|
|
US20050281798A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Targeting sites of damaged lung tissue using composition
|
|
US7678767B2
(en)
|
2004-06-16 |
2010-03-16 |
Pneumrx, Inc. |
Glue compositions for lung volume reduction
|
|
US20050281739A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue using compositions
|
|
US20050281799A1
(en)
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Targeting damaged lung tissue using compositions
|
|
CA2570261C
(en)
|
2004-07-08 |
2014-06-10 |
Pneumrx, Inc. |
Pleural effusion treatment device, method and material
|
|
HUE029170T2
(en)
|
2004-07-20 |
2017-03-28 |
Genentech Inc |
Preparations and methods for the use of angiopoietin-like protein 4
|
|
US8604185B2
(en)
|
2004-07-20 |
2013-12-10 |
Genentech, Inc. |
Inhibitors of angiopoietin-like 4 protein, combinations, and their use
|
|
SI1771474T1
(sl)
*
|
2004-07-20 |
2010-06-30 |
Genentech Inc |
Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba
|
|
CN101035803A
(zh)
*
|
2004-10-01 |
2007-09-12 |
耶鲁大学 |
Nogo－a多肽片段、变异nogo受体－1多肽、及其应用
|
|
US20060188508A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Cohen Stanley N |
Methods and compositions for modulating angiogenesis
|
|
US8252267B2
(en)
|
2005-03-30 |
2012-08-28 |
Sagres Discovery, Inc. |
DKKL-1 splice product modulators for cancer diagnosis and therapy
|
|
EP1904091A4
(en)
|
2005-07-07 |
2009-12-23 |
Univ Yale |
COMPOSITIONS AND METHODS FOR SUPPRESSING THE INHIBITION OF AXON GROWTH
|
|
CN101248083A
(zh)
*
|
2005-08-25 |
2008-08-20 |
比奥根艾迪克Ma公司 |
Nogo受体多肽和多肽片段及其用途
|
|
EP2526968A3
(en)
|
2006-01-27 |
2013-05-22 |
Biogen Idec MA Inc. |
Nogo receptor antagonists
|
|
WO2007133746A2
(en)
*
|
2006-05-15 |
2007-11-22 |
Biogen Idec Ma Inc. |
Use of nogo receptor-1 (ngr1) antagonists for promoting oligodendrocyte survival
|
|
US8568286B2
(en)
*
|
2006-06-14 |
2013-10-29 |
Cardiac Pacemakers, Inc. |
Methods to position therapeutic agents using a magnetic field
|
|
US20100297218A1
(en)
*
|
2006-09-20 |
2010-11-25 |
Pneumrx, Inc. |
Tissue adhesive compositions and methods thereof
|
|
US20090053831A1
(en)
*
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
US20080313166A1
(en)
*
|
2007-06-15 |
2008-12-18 |
Microsoft Corporation |
Research progression summary
|
|
US9128981B1
(en)
|
2008-07-29 |
2015-09-08 |
James L. Geer |
Phone assisted ‘photographic memory’
|
|
US8775454B2
(en)
*
|
2008-07-29 |
2014-07-08 |
James L. Geer |
Phone assisted ‘photographic memory’
|
|
ES2338515B1
(es)
*
|
2008-11-06 |
2011-09-14 |
Consejo Superior De Investigaciones Cientifica (Csic) 80% |
Metodo de deteccion de la telangiectasia hemorragica hereditaria.
|
|
MY196837A
(en)
|
2015-12-11 |
2023-05-03 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against various cancers
|